CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-01 | Attar Eyal C. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,146 | $0.80 | $917 | 92,772 |
| 2024-11-01 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −2,751 | $0.80 | $2K | 789,848 |
| 2024-09-30 | Choi Han Wook Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2024-09-03 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −5,576 | $0.83 | $5K | 171,796 |
| 2024-09-03 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −12,657 | $0.83 | $11K | 792,599 |
| 2024-09-03 | Quinlan Amy Vice President of Finance | Shares withheld for taxes | −4,402 | $0.83 | $4K | 50,861 |
| 2024-08-06 | Quinlan Amy Vice President of Finance | Shares withheld for taxes | −206 | $0.87 | $179 | 55,263 |
| 2024-08-06 | Attar Eyal C. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −999 | $0.87 | $869 | 93,918 |
| 2024-08-06 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −2,361 | $0.87 | $2K | 805,256 |
| 2024-08-06 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −876 | $0.87 | $762 | 177,372 |
| 2024-08-01 | Quinlan Amy Vice President of Finance | Shares withheld for taxes | −343 | $0.94 | $322 | 55,469 |
| 2024-08-01 | ANG ROBERT PRESIDENT AND CEO | Shares withheld for taxes | −2,751 | $0.94 | $3K | 807,617 |
| 2024-08-01 | Attar Eyal C. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,146 | $0.94 | $1K | 94,917 |
| 2024-08-01 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −985 | $0.94 | $926 | 178,248 |
| 2024-06-03 | Attar Eyal C. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −14,645 | $1.39 | $20K | 96,063 |
| 2024-05-23 | Namouni Fouad Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-23 | Beckman Daniella Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-23 | Lundberg Sven Ante Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-23 | Lubner David Charles Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-23 | Patterson Matthew R Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 |
Page 11 of 18 · 344 trades